Invariant Investment Management Acquires $1.08M Stake in Altria Group

The investment firm added over 18,000 shares of the tobacco giant to its portfolio in Q4 2025.

Apr. 15, 2026 at 9:07am

A cinematic close-up of intricate, industrial machinery and mechanical components in muted tones of steel grey, copper, and black, conveying the financial infrastructure and institutional power of the tobacco industry.Invariant Investment Management's new stake in Altria Group reflects ongoing institutional interest in the tobacco giant, despite regulatory headwinds.Richmond Today

Invariant Investment Management disclosed in a recent SEC filing that it acquired a new position in Altria Group, Inc. (NYSE: MO) during the fourth quarter of 2025. The firm purchased 18,817 shares of the company's stock, valued at approximately $1,083,000, making Altria its 19th largest holding.

Why it matters

Altria is one of the largest tobacco companies in the U.S., with a portfolio that includes iconic cigarette brands like Marlboro. The investment by Invariant highlights continued institutional interest in the stock, despite ongoing regulatory and public health concerns around the tobacco industry.

The details

According to the 13F filing, Invariant Investment Management added the Altria position in Q4 2025, representing about 0.7% of the firm's total portfolio. Altria's stock has seen volatility in recent years due to declining cigarette sales, vaping bans, and tobacco industry lawsuits, but the company remains a major player in the consumer staples sector.

  • Invariant Investment Management filed its 13F report for Q4 2025 on April 15, 2026.
  • The firm acquired the new Altria position during the fourth quarter of 2025.

The players

Invariant Investment Management

An investment management firm that oversees a diversified portfolio of public equities.

Altria Group, Inc.

A major American tobacco company that manufactures and markets cigarettes, smokeless tobacco, and other tobacco products.

Got photos? Submit your photos here. ›

The takeaway

Altria's continued appeal to institutional investors highlights the company's resilience, even as it navigates regulatory challenges and public health concerns around its core tobacco business. The Invariant Investment Management stake suggests that some funds see long-term value in Altria's brand power and diversification efforts.